- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
- Banker glee does not tell the whole story on Lina Khan setbacks
- Amgen resolves US regulator’s challenge to $28bn Horizon deal
- US targets 10 drugs for pricing negotiations in crackdown on costs
- Pharma: M&A strategy gets dose of bitter medicine
- M&A crackdown a ‘disaster’ for pharma sector, Pfizer executive warns
- Amgen/FTC: deal bar ignores realities of pharma food chain
- Regeneron boss backs attempt to block $28bn Amgen acquisition
- Dealmakers’ worst nightmare
- FTC warns of ‘rampant’ pharma consolidation as it targets $28bn Amgen deal
More ▼
Key statistics
On Friday, Amgen Inc (0R0T:LSE) closed at 305.75, -7.10% below its 52-week high of 329.12, set on Feb 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 280.00 |
---|---|
High | 280.00 |
Low | 280.00 |
Bid | 315.50 |
Offer | 316.00 |
Previous close | 276.75 |
Average volume | 65.77k |
---|---|
Shares outstanding | 536.38m |
Free float | 535.03m |
P/E (TTM) | 44.48 |
Market cap | 166.97bn USD |
EPS (TTM) | 7.00 USD |
Annual div (ADY) | 9.00 USD |
---|---|
Annual div yield (ADY) | 2.94% |
Div ex-date | Feb 15 2024 |
Div pay-date | Mar 07 2024 |
Next div ex-date | May 16 2024 |
Next div pay-date | Jun 07 2024 |
Data delayed at least 20 minutes, as of May 03 2024 15:19 BST.
More ▼